ArticleMolecular cancer2021

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.

Yann Cheli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.